Therapeutic potential of GV1001 analyzed in international scientific journal

Published: 2013-07-11 06:56:00
Updated: 2013-07-11 06:56:00
A flurry of articles were published on GV1001, a pancreatic cancer treatment developed Korea-based developer KAEL-GemVax.

Recently, the results of CPP (cell-penetrating peptide) related study on GV1001 was published in the latest issue of the international scientific journal Biomaterials (impa...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.